The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 27, 2022
Filed:
Jan. 04, 2019
Applicant:
Kaneka Corporation, Osaka, JP;
Inventors:
Hirokazu Sakamoto, Hyogo, JP;
Hiroetsu Suzuki, Tokyo, JP;
Kentaro Katayama, Tokyo, JP;
Yuki Tochigi, Tokyo, JP;
Assignee:
KANEKA CORPORATION, Osaka, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61K 47/10 (2017.01); C07K 14/505 (2006.01); C07K 1/107 (2006.01); A61P 13/12 (2006.01); A61K 38/17 (2006.01); A61K 47/60 (2017.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1816 (2013.01); A61K 38/17 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/60 (2017.08); A61P 13/12 (2018.01); C07K 1/107 (2013.01); C07K 14/505 (2013.01);
Abstract
A method for inhibiting renal hypofunction in a non-human animal includes administering cat-derived erythropoietin to the non-human animal. The non-human animal may have renal hypofunction. The non-human animal may have chronic kidney disease and the renal hypofunction may be caused by the chronic kidney disease. The cat-derived erythropoietin may be administered repeatedly at a time interval of 7 to 30 days.